Charlottesville, VA, United States of America

Adam Kennedy

This inventor holds 2 USPTO granted patents. Top assignee: University of Virginia Patent Foundation. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Kennedy. Retrieved from https://idiyas.com/inventor/adam-kennedy-rc6xju8j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adam Kennedy: Innovator in Immunotherapy Enhancement

Introduction

Adam Kennedy is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of immunotherapy, holding 2 patents that focus on enhancing the efficacy of therapeutic antibodies.

Latest Patents

Kennedy's latest patents include a groundbreaking invention aimed at enhancing the complement-mediated cytotoxicity of therapeutic antibodies. This invention provides a composition and method for improving the effectiveness of immunotherapies by supplying a supplemental source of complement. The focus is on targeting cells that display specific epitopes, thereby increasing the overall efficacy of these therapies.

Career Highlights

Adam Kennedy is associated with the University of Virginia Patent Foundation, where he continues to innovate and contribute to the advancement of medical therapies. His work is pivotal in the ongoing development of more effective treatments for various diseases.

Collaborations

Some of his notable coworkers include Ronald P. Taylor and Margaret A. Lindorfer, who have collaborated with him on various projects related to immunotherapy.

Conclusion

Adam Kennedy's work in enhancing immunotherapies represents a significant advancement in medical science. His innovative approach and dedication to improving therapeutic efficacy are commendable and contribute to the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…